What is MagForce?
MagForce was founded in 1997 and specializes in the development of advanced nanomedicine for innovative cancer therapies. Its nanotechnology-based therapy (NanoTherm™) is currently being used to treat patients with advanced brain cancer in the European Union. MagForce is now examining this technology as a possible treatment for patients with prostate cancer.
What is the MagForce® Clinical Study?
Clinical trials look at new ways to prevent, detect, or treat disease. They are a part of clinical research and at the heart of almost all medical advances. The goal of clinical trials is to determine if a new test or treatment is effective and safe. The MagForce® Clinical Study is being conducted to determine if the NanoTherm™ Thermal Ablation Therapy is safe and effective in the treatment of certain patients prostate cancer.
Why Do People Participate in a Clinical Trial?
People participate in clinical trials for a number of different reasons. Some people participate to help others in that the hope they are helping to contribute to the advancement of science. Some people participate in the hope of receiving a benefit from the experimental treatment for their illness or disease. Others participate in order get additional care and attention from the clinical staff conducting the trial. Finally, some may participate for the financial benefit or other type of compensation that may be available.